Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CYBX [NASD]
Cyberonics Inc.
Index- P/E24.32 EPS (ttm)2.19 Insider Own2.40% Shs Outstand26.31M Perf Week-3.20%
Market Cap1.40B Forward P/E19.58 EPS next Y2.72 Insider Trans-8.15% Shs Float25.70M Perf Month4.93%
Income59.70M PEG1.39 EPS next Q0.57 Inst Own98.60% Short Float6.42% Perf Quarter-7.21%
Sales285.10M P/S4.91 EPS this Y20.50% Inst Trans-3.52% Short Ratio4.39 Perf Half Y-12.96%
Book/sh9.91 P/B5.37 EPS next Y16.80% ROA21.30% Target Price69.89 Perf Year-22.90%
Cash/sh5.04 P/C10.56 EPS next 5Y17.50% ROE23.90% 52W Range48.19 - 73.52 Perf YTD-18.60%
Dividend- P/FCF28.83 EPS past 5Y26.80% ROI21.20% 52W High-27.57% Beta0.64
Dividend %- Quick Ratio8.10 Sales past 5Y14.50% Gross Margin90.50% 52W Low10.50% ATR1.85
Employees639 Current Ratio8.90 Sales Q/Q4.50% Oper. Margin31.00% RSI (14)54.52 Volatility3.99% 3.68%
OptionableYes Debt/Eq0.00 EPS Q/Q61.30% Profit Margin20.90% Rel Volume0.44 Prev Close53.75
ShortableYes LT Debt/Eq0.00 EarningsNov 20 BMO Payout0.00% Avg Volume375.62K Price53.25
Recom2.00 SMA202.72% SMA503.69% SMA200-9.63% Volume165,717 Change-0.93%
Aug-22-14Downgrade Canaccord Genuity Buy → Hold $63 → $52
Jun-05-14Reiterated Canaccord Genuity Buy $73 → $63
Dec-06-13Reiterated Canaccord Genuity Buy $70 → $73
Nov-22-13Reiterated Canaccord Genuity Buy $57 → $70
Jun-06-13Upgrade Northland Capital Under Perform → Market Perform $40 → $44
May-29-13Reiterated Canaccord Genuity Buy $59 → $49
Feb-25-13Reiterated Dougherty & Company Buy $56 → $58
Oct-18-12Initiated Northland Securities Under Perform $40
Sep-26-12Reiterated WBB Securities Strong Buy $60
Aug-29-12Upgrade Canaccord Genuity Hold → Buy $34 → $56
Aug-29-12Upgrade Canaccord Genuity Hold → Buy
Aug-09-12Initiated William Blair Outperform
Jan-03-12Upgrade Kaufman Bros Hold → Buy $28 → $38
Jun-03-11Upgrade WBB Securities Buy → Strong Buy
Jun-03-11Reiterated Canaccord Genuity Hold $30.50 → $26.50
Jan-31-11Reiterated WBB Securities Buy $22 → $38
Jan-04-11Initiated Jefferies Buy $37
Jul-20-10Initiated Dougherty & Company Buy $29
Feb-19-10Downgrade WBB Securities Strong Buy → Buy $17.50 → $22
Jan-04-10Upgrade Robert W. Baird Neutral → Outperform $17 → $25
Nov-27-14 01:04PM  CYBERONICS INC Financials EDGAR Online Financials
Nov-24-14 10:39AM  Today's Dead Cat Bounce Stock: Cyberonics (CYBX) at TheStreet
09:00AM  Cyberonics To Present At The 26th Annual Piper Jaffray Healthcare Conference PR Newswire
05:31AM  Cyberonics Slumps: CYBX Falls 5.1% in Session Zacks
Nov-22-14 07:07PM  10-Q for Cyberonics, Inc. Company Spotlight
Nov-21-14 10:28AM  Cyberonics (CYBX) Is Today's Perilous Reversal Stock at TheStreet -5.14%
09:10AM  Cyberonics Beats Q2 Earnings, Sales Up, EPS View Retained Zacks
07:29AM  Cyberonics (CYBX) in Focus: Stock Adds 13.4% in Session Zacks
Nov-20-14 12:08PM  Mid-Day Gainers From November 20: Kirkland's, Americas Car-Mart, Cyberonics, Epizyme, Dillard's, Best Buy Benzinga +13.40%
10:17AM  Cyberonics (CYBX) Marked As A Barbarian At The Gate at TheStreet
07:18AM  Cyberonics beats 2Q profit forecasts AP
07:07AM  Q2 2015 Cyberonics Inc Earnings Release - Before Market Open CCBN
07:03AM  CYBERONICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  Cyberonics Reports Fiscal 2015 Second Quarter Results PR Newswire
Nov-06-14 09:00AM  Cyberonics To Report Fiscal Year 2015 Second Quarter Results And Host Webcast And Conference Call On November 20, 2014 PR Newswire
Sep-26-14 10:04AM  Insider Trading Alert - CYBX, RSG And RRC Traded By Insiders at TheStreet
Sep-24-14 04:05PM  Cyberonics Sluggish on Poor Q2, Faces Reimbursement Issues Zacks
Sep-18-14 02:32PM  CYBERONICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-15-14 11:00AM  Insider Trading Alert - AMTD, CYBX And RSG Traded By Insiders at TheStreet
Sep-05-14 02:30PM  Cyberonics Down 3.6% despite Favorable ANTHEM-HF Results Zacks
Sep-02-14 09:00AM  ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure PR Newswire
Sep-01-14 03:26AM  Cyberonics device improves heart function after Boston flop Reuters
Aug-25-14 02:00PM  Cyberonics Slips to Sell on U.S. Woes, Estimate Revisions Zacks
Aug-22-14 10:54AM  Cyberonics downgraded by Canaccord Genuity Briefing.com
09:40AM  Cyberonics Misses on Q1 Earnings & Revenues, Reaffirms View Zacks
06:55AM  Cyberonics Slumps: CYBX Falls 6.1% in Session Zacks
Aug-21-14 05:00PM  Cyberonics to Participate in Upcoming Investor Conferences PR Newswire -6.11%
07:07AM  Q1 2015 Cyberonics Earnings Release - Before Market Open CCBN
07:02AM  CYBERONICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  Cyberonics Reports Fiscal 2015 First Quarter Results PR Newswire
Aug-07-14 09:00AM  Cyberonics To Report Fiscal Year 2015 First Quarter Results And Host Webcast And Conference Call On August 21, 2014 PR Newswire
Jul-09-14 02:00PM  Why is Cyberonics Downgraded to Sell? Zacks
Jul-03-14 02:20PM  Cyberonics Poised on Favorable Market Trend Zacks
Jun-25-14 01:00PM  Insider Trading Alert - RSG, ENH And CYBX Traded By Insiders at TheStreet
Jun-24-14 03:30PM  UPDATE: Sterne Agee Initiates Coverage On Cyberonics Benzinga
Jun-16-14 02:51PM  CYBERONICS INC Files SEC form 10-K, Annual Report EDGAR Online
Jun-10-14 08:00AM  Cyberonics Posts In-Line Q4 Earnings, Misses on Revs Zacks
Jun-05-14 07:54AM  Cyberonics price target lowered to $63 from $73 at Canaccord theflyonthewall.com
Jun-04-14 03:03PM  U.S./Canada daily earnings hits & misses June 4 - 1500 ET Reuters
01:03PM  3 Stocks Pulling The Health Services Industry Downward at TheStreet
12:44PM  Cyberonics Shocks Investors With Weak Profit Guidance at Investor's Business Daily
09:15AM  Wednesdays Top Health Care Stories: Valeant, Allergan, UnitedHealth Group, and Cyberonics at Motley Fool
07:07AM  Q4 2014 Cyberonics Earnings Release - Before Market Open CCBN
07:00AM  CYBERONICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  Cyberonics Reports Record Quarter And Annual Results And Provides Fiscal 2015 Guidance PR Newswire
May-28-14 09:00AM  Cyberonics To Present At The William Blair 34th Annual Growth Stock Conference PR Newswire
May-21-14 11:45AM  Insider Trading Alert - CYBX, JAZZ And EA Traded By Insiders at TheStreet
09:00AM  Cyberonics To Report Fourth Quarter And Fiscal Year 2014 Results And Host Webcast And Conference Call On June 4, 2014 PR Newswire
May-06-14 09:02AM  Cyberonics announces positive results from PuLsE study theflyonthewall.com
09:00AM  Cyberonics Announces Peer-Reviewed Publication Of VNS Therapy┬« Long-Term Comparative Effectiveness Study In Patients With Refractory Epilepsy PR Newswire
May-05-14 09:00AM  3 Stocks Breaking Out on Big Volume at TheStreet
Apr-28-14 09:02AM  CYBERONICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:00AM  Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer PR Newswire
Apr-24-14 10:00AM  On The Fly: Analyst Initiation Summary at theflyonthewall.com
Apr-16-14 02:36PM  Shock Factor: Cyberonics Link To Death, Injury Reports at Seeking Alpha
Apr-10-14 12:02PM  Insider Trading Alert - APA, DDS And CYBX Traded By Insiders at TheStreet
Apr-02-14 05:05PM  Balanced View on Cyberonics Zacks
Apr-01-14 01:50PM  Balanced View on Haemonetics Zacks
Mar-31-14 01:50PM  Balanced View on Hologic Zacks +5.26%
Mar-19-14 11:00AM  Insider Trading Alert - ACMP, CYBX And HSIC Traded By Insiders at TheStreet
Mar-18-14 02:30PM  Techne Downgraded to Sell Zacks
Mar-17-14 11:52AM  Brian Roberts, the CFO of Insulet Corporation (PODD), Interviews with The Wall Street Transcript Wall Street Transcript
Mar-07-14 11:00AM  Insider Trading Alert - VRSN, TUP And CYBX Traded By Insiders at TheStreet
Mar-06-14 02:00PM  Insider Trading Alert - IP, CYBX And JAZZ Traded By Insiders at TheStreet
Mar-03-14 02:10PM  Cyberonics Upped to Buy Zacks
Feb-27-14 04:44AM  What Can We Expect From Cyberonics This Year After A Great 2013? at Seeking Alpha
Feb-21-14 12:24PM  CYBERONICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-20-14 01:30PM  Cyberonics Management Discusses Q3 2014 Results - Earnings Call Transcript Optionetics
08:55AM  Cyberonics, Inc. Discusses Q3 2014 Results (Webcast) Optionetics
07:18AM  Cyberonics announces CE Mark approval of AspireSR generator for VNS therapy at theflyonthewall.com
07:15AM  Cyberonics Announces CE Mark Approval Of The AspireSR Generator For VNS Therapy┬« PR Newswire
07:07AM  Q3 2014 Cyberonics Earnings Release - Before Market Open CCBN
07:04AM  CYBERONICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  Cyberonics Reports Fiscal 2014 Third Quarter Results PR Newswire
Feb-19-14 04:00PM  Cyberonics To Participate In Upcoming Investor Conferences PR Newswire
Feb-07-14 08:37AM  Zacks Rank #1 Additions for Friday Zacks
Feb-06-14 01:49PM  Depression Likely The Biggest Incremental Driver For Cyberonics at Seeking Alpha
11:00AM  Insider Trading Alert - KWK, ROVI, HSY, CYBX And LRCX Traded By Insiders at TheStreet
Feb-04-14 09:00AM  Cyberonics To Report Fiscal Year 2014 Third Quarter Results And Host Webcast And Conference Call On February 20, 2014 PR Newswire
Jan-09-14 10:45AM  Insider Trading Alert - IPXL, SNCR, CYBX, KLIC And SPW Traded By Insiders at TheStreet
Jan-07-14 11:45AM  Insider Trading Alert - PNC, PANW, TUP, ED And CYBX Traded By Insiders at TheStreet
02:15AM  Natus Medical (BABY) Jumps: Stock Up 6.8% Zacks
Jan-06-14 09:00AM  Cyberonics To Present At The 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-02-14 03:35PM  Good News for Quidel Zacks
Dec-26-13 02:20PM  Cyberonics Pinned at Neutral Zacks
Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that uses pulsed electrical signals applied to the vagus nerve for the treatment of refractory epilepsy and treatment-resistant depression. It is also engaged in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alch DarrenVP Genl Counsel Asst SecNov 24Sale54.472,422131,92215,990Nov 25 09:29 AM
MORRISON HUGH MDirectorNov 24Sale53.792,454132,00910,315Nov 25 08:58 PM
Morris Milton MayoSR VP Research & DevelopmentNov 24Sale54.187,547408,88326,599Nov 25 08:56 PM
WISE DAVID SSR VP & Chief Admin OfficerNov 03Sale52.192,000104,38863,007Nov 04 06:02 PM
Alch DarrenVP Genl Counsel Asst SecOct 23Sale51.5623612,16819,323Oct 24 12:22 PM
Moore Daniel JeffreyPresident & CEOOct 15Option Exercise25.714,000102,840162,569Oct 17 11:08 AM
Moore Daniel JeffreyPresident & CEOOct 15Sale50.047,000350,276155,569Oct 17 11:08 AM
WISE DAVID SSR VP & Chief Admin OfficerOct 01Sale50.092,000100,17270,120Oct 02 11:09 AM
Alch DarrenVP Genl Counsel Asst SecSep 11Option Exercise14.721,00014,72020,794Sep 12 04:59 PM
Alch DarrenVP Genl Counsel Asst SecSep 11Sale53.721,00053,72019,794Sep 12 04:59 PM
MORRISON HUGH MDirectorSep 10Sale54.1350027,06310,454Sep 12 05:00 PM
Moore Daniel JeffreyPresident & CEOSep 05Sale55.304,750262,6652,586Sep 09 05:03 PM
WISE DAVID SSR VP & Chief Admin OfficerSep 02Sale56.332,000112,65572,120Sep 04 11:03 AM
Morris Milton MayoSR VP Research & DevelopmentAug 29Option Exercise16.3813,000212,94047,146Sep 03 01:52 PM
Morris Milton MayoSR VP Research & DevelopmentAug 29Sale57.1513,000743,01134,146Sep 03 01:52 PM
Alch DarrenVP Genl Counsel Asst SecAug 25Sale56.9623613,44319,794Aug 27 01:10 PM
Moore Daniel JeffreyPresident & CEOAug 15Option Exercise25.714,000102,840168,569Aug 19 09:48 AM
Moore Daniel JeffreyPresident & CEOAug 15Sale60.747,000425,160161,569Aug 19 09:48 AM
Moore Daniel JeffreyPresident & CEOAug 05Sale60.564,750287,6774,086Aug 07 10:06 AM
Alch DarrenVP Genl Counsel Asst SecJul 23Sale58.6223513,77620,030Jul 24 03:48 PM
Moore Daniel JeffreyPresident & CEOJul 15Option Exercise25.714,000102,840171,569Jul 17 07:29 AM
Moore Daniel JeffreyPresident & CEOJul 15Sale59.367,000415,510164,569Jul 17 07:29 AM
Moore Daniel JeffreyPresident & CEOJul 07Sale61.734,750293,2265,586Jul 08 05:35 PM
Morris Milton MayoSR VP Research & DevelopmentJun 20Sale58.069,224535,52134,146Jun 24 10:33 AM
Moore Daniel JeffreyPresident & CEOJun 16Option Exercise25.714,000102,840176,661Jun 18 05:10 PM
Moore Daniel JeffreyPresident & CEOJun 16Sale57.187,000400,238169,661Jun 18 05:10 PM
Moore Daniel JeffreyPresident & CEOJun 05Sale57.204,750271,7137,086Jun 09 09:22 AM
BROWNE GREGORY HSR VP Finance & CFOMay 16Sale59.231,50088,84561,942May 20 08:56 AM
Moore Daniel JeffreyPresident & CEOMay 15Option Exercise25.234,000100,914168,051May 19 06:02 PM
Moore Daniel JeffreyPresident & CEOMay 15Sale59.257,000414,735161,051May 19 06:02 PM
Moore Daniel JeffreyPresident & CEOMay 05Sale62.084,750294,8908,586May 07 01:10 PM
WISE DAVID SSR VP & Chief Admin OfficerMay 05Sale62.092,000124,18073,055May 07 01:05 PM
BROWNE GREGORY HSR VP Finance & CFOApr 16Sale61.611,50092,41863,442Apr 17 05:13 PM
Moore Daniel JeffreyPresident & CEOApr 15Option Exercise24.334,00097,320165,163Apr 17 05:11 PM
Moore Daniel JeffreyPresident & CEOApr 15Sale61.227,000428,572158,163Apr 17 05:11 PM
Moore Daniel JeffreyPresident & CEOApr 07Sale61.814,750293,61510,086Apr 09 11:45 AM
WISE DAVID SSR VP & Chief Admin OfficerApr 01Sale65.562,000131,13075,055Apr 03 10:23 AM
Moore Daniel JeffreyPresident & CEOMar 17Option Exercise24.334,00097,320168,163Mar 18 06:50 PM
BROWNE GREGORY HSR VP Finance & CFOMar 17Sale66.601,50099,89564,942Mar 18 06:48 PM
Moore Daniel JeffreyPresident & CEOMar 17Sale66.627,000466,309161,163Mar 18 06:50 PM
Moore Daniel JeffreyPresident & CEOMar 05Sale69.594,750330,53011,586Mar 06 04:01 PM
WISE DAVID SSR VP & Chief Admin OfficerMar 03Sale67.582,000135,15677,055Mar 05 10:54 AM
Jackson Guy C.DirectorFeb 28Option Exercise19.758,000158,00042,288Mar 04 12:06 PM
Jackson Guy C.DirectorFeb 28Sale69.088,000552,67134,288Mar 04 12:06 PM
Novak Alfred JDirectorFeb 27Sale67.961,27486,58114,705Mar 03 12:02 PM
Olin Bryan DVP Clinical Quality RegulatoryFeb 26Option Exercise20.9310,672223,41674,096Feb 28 10:15 AM
Olin Bryan DVP Clinical Quality RegulatoryFeb 26Sale68.3410,672729,31563,424Feb 28 10:15 AM
Novak Alfred JDirectorFeb 25Sale68.753,621248,94415,979Feb 27 03:29 PM
Alch DarrenVP Genl Counsel Asst SecFeb 24Option Exercise16.721,75029,26320,624Feb 26 10:21 AM
MORRISON HUGH MDirectorFeb 24Sale69.3550034,67510,954Feb 26 10:23 AM
Alch DarrenVP Genl Counsel Asst SecFeb 24Sale69.191,750121,09118,874Feb 26 10:21 AM
Moore Daniel JeffreyPresident & CEOFeb 18Option Exercise24.334,00097,320177,783Feb 20 05:03 PM
BROWNE GREGORY HSR VP Finance & CFOFeb 18Sale72.451,500108,67566,442Feb 20 05:01 PM
Moore Daniel JeffreyPresident & CEOFeb 18Sale72.487,000507,366170,783Feb 20 05:03 PM
SIMPSON RANDAL LVP OperationsFeb 06Sale66.173,000198,51042,285Feb 07 10:34 AM
Moore Daniel JeffreyPresident & CEOFeb 05Sale66.364,750315,18813,086Feb 07 10:31 AM
WISE DAVID SSR VP & Chief Admin OfficerFeb 03Sale65.572,000131,13379,055Feb 05 10:30 AM
BROWNE GREGORY HSR VP Finance & CFOJan 16Sale69.321,500103,97967,942Jan 21 10:13 AM
Moore Daniel JeffreyPresident & CEOJan 15Option Exercise24.334,00097,320180,783Jan 17 11:37 AM
Moore Daniel JeffreyPresident & CEOJan 15Sale68.817,000481,691173,783Jan 17 11:37 AM
SIMPSON RANDAL LVP OperationsJan 06Sale64.893,000194,67045,285Jan 08 04:08 PM
Moore Daniel JeffreyPresident & CEOJan 06Sale64.724,750307,40214,586Jan 08 04:06 PM
WISE DAVID SSR VP & Chief Admin OfficerJan 02Sale63.652,000127,29581,055Jan 06 01:48 PM
Moore Daniel JeffreyPresident & CEODec 16Option Exercise24.334,00097,320183,783Dec 18 10:20 AM
Moore Daniel JeffreyPresident & CEODec 16Sale64.597,000452,134176,783Dec 18 10:20 AM
BROWNE GREGORY HSR VP Finance & CFODec 16Sale64.601,50096,90369,442Dec 18 10:12 AM
MORRISON HUGH MDirectorDec 10Sale66.541,00066,54011,454Dec 12 09:30 AM
Novak Alfred JDirectorDec 09Sale67.492,750185,59219,600Dec 11 10:28 AM
BROWNE GREGORY HSR VP Finance & CFODec 09Sale68.0110,000680,09770,942Dec 11 10:26 AM
Moore Daniel JeffreyPresident & CEODec 05Sale69.484,750330,04216,086Dec 09 10:56 AM
Verratti MarkVP Global SalesDec 03Option Exercise37.9018,750710,62571,469Dec 05 10:05 AM
Verratti MarkVP Global SalesDec 03Sale71.1218,7501,333,47852,719Dec 05 10:05 AM
SIMPSON RANDAL LVP OperationsDec 02Option Exercise13.885,00069,40053,285Dec 04 12:31 PM
WISE DAVID SSR VP & Chief Admin OfficerDec 02Sale69.622,000139,24983,055Dec 04 12:33 PM
SIMPSON RANDAL LVP OperationsDec 02Sale69.235,000346,16948,285Dec 04 12:31 PM